Show simple item record

dc.creatorVerre, Vladimiro
dc.creatorMilesi, Dario
dc.creatorPetelski, Natalia
dc.date2013-09-24
dc.identifierhttps://www.jotmi.org/index.php/GT/article/view/art402
dc.identifier10.4067/S0718-27242013000400012
dc.descriptionThe article presents a study on the use of secrecy in Argentine biopharmaceutical firms that innovate through public-private cooperation. When innovation is achieved by cooperating with public and external sources of knowledge, the company is exposed to higher risks that critical knowledge leaks out to potential competitors, undermining the effectiveness of secrecy. To investigate this issue, study cases have been conducted on firms whose innovation projects are carried out by cooperating with public R&D institutions. The results suggest that the specific features of cooperation determine different possibilities for firms to face those risks, adapt its strategy of appropriation and protect the generated knowledge.es-ES
dc.formatapplication/pdf
dc.languagespa
dc.publisherFacultad de Economía y Negocios, Universidad Alberto Hurtadoen-US
dc.relationhttps://www.jotmi.org/index.php/GT/article/view/art402/865
dc.rightsCopyright (c) 2013 Journal of Technology Management & Innovationen-US
dc.rightshttps://creativecommons.org/licenses/by-sa/4.0en-US
dc.sourceJournal of Technology Management & Innovation; Vol. 8 No. 3 (2013); 127-138en-US
dc.sourceJournal of Technology Management & Innovation; Vol. 8 Núm. 3 (2013); 127-138es-ES
dc.source0718-2724
dc.subjectinnovaciónes-ES
dc.subjectcooperación en I Des-ES
dc.subjectsecreto industriales-ES
dc.subjectapropiaciónes-ES
dc.subjectbiofarmacéuticoes-ES
dc.titleSecreto Industrial y Cooperación Público-privada en I+D en el Sector Biofarmacéutico Argentinoes-ES
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typeArtículo revisado por paresen-US


This item appears in the following Collection(s)

Show simple item record